Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL353832

COc1ncccc1C(=O)NC1=CC(=O)C2OC2C1O.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARK7 Q99497 1/20 0.45
BRD4 O60885 1/20 0.38
BRPF1 P55201 1/20 0.38
PPARG P37231 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
MAP3K5 Q99683 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
GAA P10253 3/20 0.38
MAPT P10636 1/20 0.38
GPR6 P46095 2/20 0.37
NPC1 O15118 1/20 0.36
TSHR P16473 1/20 0.36
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 1/20 0.36
POLB P06746 1/20 0.36
TAS2R8 Q9NYW2 1/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL353842 0.93 PARK7 (0.50) PARK7BRD4BRPF1PPARGRXFP1
SCHEMBL353833 0.84 BRD4 (0.38) PARK7BRD4BRPF1PPARGRXFP1
Trifluoroacetic Acid SCHEMBL352372 0.84 PARK7 (0.45) PARK7MAPTNPC1POLBKMT2A
SCHEMBL351903 0.80 PARK7 (0.45) PARK7BRD4BRPF1MAPTTSHR
SCHEMBL351825 0.79 PARK7 (0.48) PARK7BRD4BRPF1GAANPC1
SCHEMBL351942 0.75 PARK7 (0.45) PARK7
SCHEMBL16649916 0.75 PARK7 (0.58) PARK7RXFP1MAPTNPC1TSHR
SCHEMBL16649963 0.75 PARK7 (0.42) PARK7GAAMAPTNPC1ALDH1A1
SCHEMBL351888 0.74 PARK7 (0.46) PARK7
SCHEMBL352431 0.73 PARK7 (0.56) PARK7MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411376-B1 INHIBITORS OF NF-KB PROFECTUS BIOSCIENCES INC (US) 2015-04-22 EP claimed
US-8629164-B2 Inhibitors of NF-κB PROFECTUS BIOSCIENCES, INC. (US) 2014-01-14 US claimed
US-20120015952-A1 Inhibitors of NF-KB PROFECTUS BIOSCIENCES, INC. (US) 2012-01-19 US claimed
US-8629164-B2 Inhibitors of NF-κB PROFECTUS BIOSCIENCES, INC. (US) 2014-01-14 US disclosed
US-20120015952-A1 Inhibitors of NF-KB PROFECTUS BIOSCIENCES, INC. (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015952-A1 Inhibitors of NF-KB NFKBIA, IKBKB, IKBKG PARK7 3327/4885BRD4 1058/4885BRPF1 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.